NCT01852214View on ClinicalTrials.gov

Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions
Diabetes MellitusCoronary Artery Disease
Interventions
DRUG

Prasugrel

Patients receiving prasugrel will be treated with 60mg loading dose and 10mg maintenance dose

DRUG

Ticagrelor

Patients receiving ticagrelor will be treated with a 180mg loading dose and 90mg bid maintenance dose

Trial Locations (1)

32209

University of Florida, Jacksonville

All Listed Sponsors
lead

University of Florida

OTHER

NCT01852214 - Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes | Biotech Hunter | Biotech Hunter